Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications

The coronavirus disease 2019 (COVID-19) epidemic is currently raging around the world at a rapid speed. Among COVID-19 patients, SARS-CoV-2-associated acute respiratory distress syndrome (ARDS) is the main contribution to the high ratio of morbidity and mortality. However, clinical manifestations be...

Descripción completa

Detalles Bibliográficos
Autores principales: Ting, Ching-Tse, Chen, Bor-Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998971/
https://www.ncbi.nlm.nih.gov/pubmed/35409008
http://dx.doi.org/10.3390/ijms23073649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998971/
https://www.ncbi.nlm.nih.gov/pubmed/35409008
http://dx.doi.org/10.3390/ijms23073649

Ejemplares similares